MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
29.04
-2.93 (-9.16%)
At close: Apr 28, 2026, 4:00 PM EDT
29.00
-0.04 (-0.14%)
Pre-market: Apr 29, 2026, 6:46 AM EDT
MBX Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 19.2 | 10.98 | 6.98 | 3.86 |
| Research & Development | 78.86 | 57.22 | 28.33 | 21.3 |
| Operating Expenses | 98.06 | 68.19 | 35.31 | 25.16 |
| Operating Income | -98.06 | -68.19 | -35.31 | -25.16 |
| Interest Expense | - | - | - | -0.37 |
| Interest & Investment Income | 7.47 | 3.34 | 1.7 | 0.35 |
| Other Non Operating Income (Expenses) | - | - | - | -0.07 |
| EBT Excluding Unusual Items | -90.58 | -64.85 | -33.61 | -25.26 |
| Gain (Loss) on Sale of Investments | 3.61 | 2.93 | 1.04 | 0.03 |
| Other Unusual Items | - | - | - | -0.9 |
| Pretax Income | -86.97 | -61.92 | -32.56 | -26.14 |
| Net Income | -86.97 | -61.92 | -32.56 | -26.14 |
| Net Income to Common | -86.97 | -61.92 | -32.56 | -26.14 |
| Shares Outstanding (Basic) | 37 | 11 | 1 | 1 |
| Shares Outstanding (Diluted) | 37 | 11 | 1 | 1 |
| Shares Change (YoY) | 243.01% | 944.70% | 52.73% | - |
| EPS (Basic) | -2.38 | -5.82 | -31.96 | -39.18 |
| EPS (Diluted) | -2.38 | -5.82 | -31.96 | -39.18 |
| Free Cash Flow | -81.88 | -55.56 | -32.11 | -23.56 |
| Free Cash Flow Per Share | -2.24 | -5.22 | -31.52 | -35.33 |
| EBITDA | -97.81 | -67.95 | -35.15 | -25.11 |
| D&A For EBITDA | 0.25 | 0.24 | 0.16 | 0.06 |
| EBIT | -98.06 | -68.19 | -35.31 | -25.16 |
Source: S&P Capital IQ. Standard template.
Financial Sources.